Dyslipidemia is a prominent factor for the development of cardiovascular diseases that are the leading cause of death in the world, with left ventricular hypertrophy being one of these. Changes in the lipid profile are also responsible for the oxidative stress that affects several organs, and the liver is one of the most affected. Such involvement triggers diseases that affect the organ structurally and functionally. Herbal medicines in recent years are emerging as an alternative in the treatment of various disorders, such as dyslipidemia. The aim of this work is evaluate the effects of the dried extract of Passiflora incarnata on dyslipidemia, left ventricular hypertrophy and hepatic oxidative stress of dyslipidemic mice. The 4-month-old male
